Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Production and Expansion of Chimeric Antigen Receptor (CAR)-Natural Killer (NK) Cells From Patients Affected by Lympho or Myeloproliferative Disorders and From Healthy Donors

NCT06727383 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT06727383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06727383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Production and Expansion of Chimeric Antigen Receptor (CAR)-Natural Killer (NK) Cells From Patients Affected by Lympho or Myeloproliferative Disorders and From Healthy Donors
Lead sponsor
European Institute of Oncology
Phase
Not applicable
Overall status
Unknown status
Start date
December 21, 2022
Completion date
December 21, 2025
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy donors, lymphoproliferative disorders, myeloproliferative diseases